ARTICLE
10 August 2015

Injuries Board Authorisation Required In Personal Injury Claims Arising From A Product Liability Claim

M
Matheson

Contributor

Established in 1825 in Dublin, Ireland and with offices in Cork, London, New York, Palo Alto and San Francisco, more than 700 people work across Matheson’s six offices, including 96 partners and tax principals and over 470 legal and tax professionals. Matheson services the legal needs of internationally focused companies and financial institutions doing business in and from Ireland. Our clients include over half of the world’s 50 largest banks, 6 of the world’s 10 largest asset managers, 7 of the top 10 global technology brands and we have advised the majority of the Fortune 100.
The Plaintiff in this case sued for negligence and product liability against DePuy International Limited for defective product and device failure.
Ireland Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Following an application for a preliminary ruling by the Plaintiff in a High Court case1, it was held that any claim for damages for personal injury arising from a claim for product liability against a producer, as defined under the Liability for Defective Products Act, 1991, requires an authorisation from the Injuries Board prior to court proceedings being issued.

The Plaintiff in this case sued for negligence and product liability against DePuy International Limited for defective product and device failure.  The device used was a medical device and fitted during a surgical procedure.  The Plaintiff did not make an application through the Injuries Board prior to issuing proceedings, relying on the statutory exclusion that medical negligence claims do not require an authorisation. 

The court did not accept the Plaintiff's argument that her claim for damages against this Defendant arose out of the provision of a health care service and therefore, an authorisation was required. 

Importantly, there were no allegations made by the Plaintiff against DePuy that it was negligent in the provision of any health service, or that it carried out any surgical or medical procedure in a negligent manner.  Further, there were no allegations of negligence against a medical practitioner or the Hospital.

The Plaintiff in this matter had issued a second set of proceedings, protectively, in which an Injuries Board Authorisation was obtained.  She is therefore, likely to allow the set of proceedings under review to lapse.

This case will have implications for Irish cases involving defective medical products where no authorisation has been obtained and only the manufacturer, producer or supplier have been sued.

Footnote

1. Murphy -v- DePuy International Limited, [2015] IEHC 153

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
10 August 2015

Injuries Board Authorisation Required In Personal Injury Claims Arising From A Product Liability Claim

Ireland Food, Drugs, Healthcare, Life Sciences

Contributor

Established in 1825 in Dublin, Ireland and with offices in Cork, London, New York, Palo Alto and San Francisco, more than 700 people work across Matheson’s six offices, including 96 partners and tax principals and over 470 legal and tax professionals. Matheson services the legal needs of internationally focused companies and financial institutions doing business in and from Ireland. Our clients include over half of the world’s 50 largest banks, 6 of the world’s 10 largest asset managers, 7 of the top 10 global technology brands and we have advised the majority of the Fortune 100.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More